by Eric Christianson | Sep 27, 2023 | Cardiovascular Medication and Disease State Clinical Pearls
Angiotensin Receptor Blockers are one of the most commonly used drug classes to manage hypertension. Many clinicians prefer using these medications even over ACE inhibitors to reduce the risk of running into the ACE inhibitor-related cough. This is the primary...
by Eric Christianson | Sep 24, 2023 | Respiratory Medication and Disease State Clinical Pearls
I’m so excited to try something different today and interview one of my great friends! Beth Zerr, PharmD, BCACP was able to share some wisdom on one of the topic areas that she teaches to not only patients but pharmacy students. We cover asthma pharmacology and...
by Eric Christianson | Sep 20, 2023 | Endocrine Medication and Disease State Clinical Pearls
A few months back, I compared one of the newest SGLT2 inhibitors in bexagliflozin to the other agents in this class of medication. To sum up my analysis, bexagliflozin provided nothing significantly different from the other SGLT2 inhibitors. In fact, it has less...
by Eric Christianson | Sep 17, 2023 | Cardiovascular Medication and Disease State Clinical Pearls
ACE Inhibitors have been a workhorse in managing blood pressure for years. While lisinopril is the most commonly used agent that I see in practice, I thought it would be helpful to put together an ACE Inhibitor Comparison table to share with the audience and highlight...
by Eric Christianson | Sep 13, 2023 | Cardiovascular Medication and Disease State Clinical Pearls
One of the most common medication review requests I get from clinical staff in long term care and assisted living facilities is identifying medications that may be contributing to falls. Identifying low blood pressure as a potential contributing factor is usually...
